tiprankstipranks
Advertisement
Advertisement
Novo Nordisk’s CagriSema Trial Puts Next-Generation Obesity Strategy in Focus
PremiumCompany AnnouncementsNovo Nordisk’s CagriSema Trial Puts Next-Generation Obesity Strategy in Focus
5d ago
Eli Lilly Stock (LLY) Jumps 5% as CVS Health Covers Its Weight-Loss Drugs
Premium
Market News
Eli Lilly Stock (LLY) Jumps 5% as CVS Health Covers Its Weight-Loss Drugs
6d ago
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.46%
Premium
The Fly
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.46%
7d ago
Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial
PremiumCompany AnnouncementsNovo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial
12d ago
Novo Nordisk’s AMAZE 4 Trial Targets Obesity and Sleep Apnea for Next Growth Leg
Premium
Company Announcements
Novo Nordisk’s AMAZE 4 Trial Targets Obesity and Sleep Apnea for Next Growth Leg
12d ago
Novo Nordisk Wins EMA Panel Backing for First Oral Wegovy Obesity Pill in EU
Premium
Company Announcements
Novo Nordisk Wins EMA Panel Backing for First Oral Wegovy Obesity Pill in EU
12d ago
Novo Nordisk’s AMAZE 2 Trial: A New Weight-Loss Shot Targets Growth Beyond Semaglutide
PremiumCompany AnnouncementsNovo Nordisk’s AMAZE 2 Trial: A New Weight-Loss Shot Targets Growth Beyond Semaglutide
15d ago
Novo Nordisk’s AMAZE 12 Trial: Next Wave in Obesity Maintenance Drugs
Premium
Company Announcements
Novo Nordisk’s AMAZE 12 Trial: Next Wave in Obesity Maintenance Drugs
15d ago
Moderately bullish activity in Novo Nordisk with shares up 0.6%
Premium
The Fly
Moderately bullish activity in Novo Nordisk with shares up 0.6%
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100